WO2003029485A3 - Specific differential display arrays - Google Patents
Specific differential display arrays Download PDFInfo
- Publication number
- WO2003029485A3 WO2003029485A3 PCT/DK2002/000653 DK0200653W WO03029485A3 WO 2003029485 A3 WO2003029485 A3 WO 2003029485A3 DK 0200653 W DK0200653 W DK 0200653W WO 03029485 A3 WO03029485 A3 WO 03029485A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- differential display
- specific differential
- display arrays
- stressed
- identifying
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02800000A EP1434883A2 (en) | 2001-10-02 | 2002-10-02 | Specific differential display arrays |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200101438 | 2001-10-02 | ||
DKPA200101438 | 2001-10-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003029485A2 WO2003029485A2 (en) | 2003-04-10 |
WO2003029485A3 true WO2003029485A3 (en) | 2004-03-04 |
Family
ID=8160744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2002/000653 WO2003029485A2 (en) | 2001-10-02 | 2002-10-02 | Specific differential display arrays |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1434883A2 (en) |
WO (1) | WO2003029485A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8946177B2 (en) | 2004-11-12 | 2015-02-03 | Mima Therapeutics, Inc | Methods and compositions involving miRNA and miRNA inhibitor molecules |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2290074B1 (en) | 2004-05-28 | 2014-12-17 | Asuragen, Inc. | Methods and compositions involving microRNA |
AU2007299828C1 (en) | 2006-09-19 | 2014-07-17 | Interpace Diagnostics, Llc | MicroRNAs differentially expressed in pancreatic diseases and uses thereof |
CA2663962A1 (en) | 2006-09-19 | 2008-03-27 | Asuragen, Inc. | Mir-15, mir-26, mir-31,mir-145, mir-147, mir-188, mir-215, mir-216, mir-331, mmu-mir-292-3p regulated genes and pathways as targets for therapeutic intervention |
EP2198050A1 (en) | 2007-09-14 | 2010-06-23 | Asuragen, INC. | Micrornas differentially expressed in cervical cancer and uses thereof |
US8258111B2 (en) | 2008-05-08 | 2012-09-04 | The Johns Hopkins University | Compositions and methods related to miRNA modulation of neovascularization or angiogenesis |
WO2011108930A1 (en) | 2010-03-04 | 2011-09-09 | Interna Technologies Bv | A MiRNA MOLECULE DEFINED BY ITS SOURCE AND ITS DIAGNOSTIC AND THERAPEUTIC USES IN DISEASES OR CONDITIONS ASSOCIATED WITH EMT |
WO2012005572A1 (en) | 2010-07-06 | 2012-01-12 | Interna Technologies Bv | Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
AU2011329772B2 (en) | 2010-11-17 | 2017-05-04 | Interpace Diagnostics, Llc | miRNAs as biomarkers for distinguishing benign from malignant thyroid neoplasms |
EP2474617A1 (en) | 2011-01-11 | 2012-07-11 | InteRNA Technologies BV | Mir for treating neo-angiogenesis |
US20140057295A1 (en) | 2011-02-28 | 2014-02-27 | Barbara J. Stegmann | Anti-mullerian hormone changes in pregnancy and prediction of adverse pregnancy outcomes and gender |
US9644241B2 (en) | 2011-09-13 | 2017-05-09 | Interpace Diagnostics, Llc | Methods and compositions involving miR-135B for distinguishing pancreatic cancer from benign pancreatic disease |
US20130157884A1 (en) | 2011-10-26 | 2013-06-20 | Asuragen, Inc. | Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts |
WO2013063544A1 (en) | 2011-10-27 | 2013-05-02 | Asuragen, Inc. | Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors |
EP2870263A1 (en) | 2012-07-03 | 2015-05-13 | InteRNA Technologies B.V. | Diagnostic portfolio and its uses |
US20140100124A1 (en) | 2012-10-04 | 2014-04-10 | Asuragen, Inc. | Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions |
CA2907377A1 (en) | 2013-03-15 | 2014-09-18 | Baylor Research Institute | Tissue and blood-based mirna biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer |
ES2935257T3 (en) | 2013-03-15 | 2023-03-03 | Univ Chicago | Methods and Compositions Related to T Cell Activity |
WO2014151551A1 (en) | 2013-03-15 | 2014-09-25 | Baylor Research Institute | Ulcerative colitis (uc)-associated colorectal neoplasia markers |
EP3704250A1 (en) | 2017-11-03 | 2020-09-09 | InteRNA Technologies B.V. | Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation |
CN108663462B (en) * | 2018-08-06 | 2021-04-13 | 通标标准技术服务(上海)有限公司 | Method for measuring vitamin A, D and E in milk powder |
KR20210151944A (en) | 2019-04-12 | 2021-12-14 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | Compositions and methods for increasing muscle mass and oxidative metabolism |
WO2024028794A1 (en) | 2022-08-02 | 2024-02-08 | Temple Therapeutics BV | Methods for treating endometrial and ovarian hyperproliferative disorders |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998051789A2 (en) * | 1997-05-13 | 1998-11-19 | Display Systems Biotech A/S | A METHOD TO CLONE mRNAs AND DISPLAY OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS (DODET) |
WO1999049894A1 (en) * | 1998-04-01 | 1999-10-07 | Genentech, Inc. | Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders |
WO1999055913A2 (en) * | 1998-04-27 | 1999-11-04 | Sidney Kimmel Cancer Center | Reduced complexity nucleic acid targets and methods of using same |
WO2000000646A1 (en) * | 1998-06-30 | 2000-01-06 | The Scripps Research Institute | METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
GB2350676A (en) * | 1999-06-01 | 2000-12-06 | Proteome Sciences Plc | Method of screening for an agent for treating insulin-related disorders |
WO2001002560A1 (en) * | 1999-06-29 | 2001-01-11 | Autogen Research Pty. Ltd. | Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
WO2001063295A2 (en) * | 2000-02-24 | 2001-08-30 | Oxford Glycosciences (Uk) Ltd. | Dpi-6, a therapeutic biomarker in neurological disorders |
WO2002095064A1 (en) * | 2001-05-18 | 2002-11-28 | Azign Bioscience A/S | Transporter arrays and methods and kits for producing and using the arrays |
-
2002
- 2002-10-02 WO PCT/DK2002/000653 patent/WO2003029485A2/en not_active Application Discontinuation
- 2002-10-02 EP EP02800000A patent/EP1434883A2/en not_active Withdrawn
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998051789A2 (en) * | 1997-05-13 | 1998-11-19 | Display Systems Biotech A/S | A METHOD TO CLONE mRNAs AND DISPLAY OF DIFFERENTIALLY EXPRESSED TRANSCRIPTS (DODET) |
WO1999049894A1 (en) * | 1998-04-01 | 1999-10-07 | Genentech, Inc. | Antagonists to growth arrest specific gene 6 to treat insulin-resistant disorders |
WO1999055913A2 (en) * | 1998-04-27 | 1999-11-04 | Sidney Kimmel Cancer Center | Reduced complexity nucleic acid targets and methods of using same |
WO2000000646A1 (en) * | 1998-06-30 | 2000-01-06 | The Scripps Research Institute | METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS |
GB2350676A (en) * | 1999-06-01 | 2000-12-06 | Proteome Sciences Plc | Method of screening for an agent for treating insulin-related disorders |
WO2001002560A1 (en) * | 1999-06-29 | 2001-01-11 | Autogen Research Pty. Ltd. | Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
WO2001063295A2 (en) * | 2000-02-24 | 2001-08-30 | Oxford Glycosciences (Uk) Ltd. | Dpi-6, a therapeutic biomarker in neurological disorders |
WO2002095064A1 (en) * | 2001-05-18 | 2002-11-28 | Azign Bioscience A/S | Transporter arrays and methods and kits for producing and using the arrays |
Non-Patent Citations (3)
Title |
---|
FRED REGNIER ET AL: "Multidimensional Chromatography and the Signature Peptide Approach to Proteomics", LCGC, vol. 19, no. 2, February 2001 (2001-02-01), pages 200 - 213, XP002232798, Retrieved from the Internet <URL:http:www.chromatographyonline.com> [retrieved on 20030226] * |
GYGI STEVEN P ET AL: "Quantitative analysis of complex protein mixtures using isotope-coded affinity tags.", NATURE BIOTECHNOLOGY, vol. 17, no. 10, October 1999 (1999-10-01), pages 994 - 999, XP002232658, ISSN: 1087-0156 * |
YAMANO MAYUMI ET AL: "Corticotropin-releasing hormone1 receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 292, no. 1, January 2000 (2000-01-01), pages 181 - 187, XP002232660, ISSN: 0022-3565 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8946177B2 (en) | 2004-11-12 | 2015-02-03 | Mima Therapeutics, Inc | Methods and compositions involving miRNA and miRNA inhibitor molecules |
Also Published As
Publication number | Publication date |
---|---|
EP1434883A2 (en) | 2004-07-07 |
WO2003029485A2 (en) | 2003-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003029485A3 (en) | Specific differential display arrays | |
AU2002336367A1 (en) | Adamts13 genes and proteins and variants, and uses thereof | |
AU2001238212A1 (en) | Modified fluorescent proteins | |
WO2003012089A3 (en) | Crystal structure of beta-site app cleaving enzyme (bace) and use thereof | |
AU2002368056A1 (en) | Novel pla2 enzyme, it's antibody, enzyme inhibitor and use and the preparation methods thereof | |
AU2002243750A1 (en) | Novel nucleic acid and polypeptide molecules | |
EP1369477A4 (en) | METHOD OF CONSTRUCTING cDNA TAG FOR IDENTIFYING EXPRESSED GENE AND METHOD OF ANALYZING GENE EXPRESSION | |
WO2004029835A3 (en) | System and method for associating different types of media content | |
AU2002258630A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002306860A1 (en) | Isolated human nadph oxidase, nucleic acid molecules encoding said proteins, and uses thereof | |
AU2002258617A1 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
WO2003010309A1 (en) | Oligonucleotides for detecting tubercle bacillus and method therefor | |
AU2002303137A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
AU2002257075A1 (en) | Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof | |
EP1383908A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1385991A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
WO2002101393A3 (en) | Method for identifying interaction between proteins and dna fragments of a genome | |
WO2002063013A3 (en) | Human acid phosphatase gene | |
WO2003050748A3 (en) | Genetic analysis of gene expression in heterosis | |
AU2003222241A1 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
EP1383876A4 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
AU2002330205A1 (en) | Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof | |
AU2001292647A1 (en) | Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof | |
AU2002307004A1 (en) | Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof | |
AU2002258635A1 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BY BZ CA CH CN CO CR CU CZ DE DM DZ EC EE ES FI GB GD GE GH HR HU ID IL IN IS JP KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NO NZ OM PH PL PT RU SD SE SG SI SK SL TJ TM TN TR TZ UA UG US UZ VC VN YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ UG ZM ZW AM AZ BY KG KZ RU TJ TM AT BE BG CH CY CZ DK EE ES FI FR GB GR IE IT LU MC PT SE SK TR BF BJ CF CG CI GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002800000 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2002800000 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002800000 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |